BOGOTA, Colombia – An administrative decision in Brazil canceled the patent for bevacizumab following a lawsuit filed by domestic generics manufacturers. The Brazilian Association of Industries of Generics (ProGenéricos in Portuguese), which represents the companies that distribute around 90 percent of the generics sold in Brazil, took on the patent at the source.

BOGOTA, Colombia – In a decision that caused a stir here, the Council of State Colombia, a court of last resort, not only opened the doors for unregistered drugs to enter the country, but also makes it possible for doctors to use drugs beyond their registered scope.

BOGOTA, Colombia – Famous for its voluminous red tape, Brazil is now looking to make deals in the biopharmaceutical space a little easier, or at least easier to plan.